Erythropoietin and the Nervous System Hard cover - 2005
by Ahmet Höke
- New
- Hardcover
Description
Standard delivery: 7 to 12 days
About Ria Christie Collections Greater London, United Kingdom
Hello We are professional online booksellers. We sell mostly new books and textbooks and we do our best to provide a competitive price. We are based in Greater London, UK. We pride ourselves by providing a good customer service throughout, shipping the items quickly and replying to customer queries promptly. Ria Christie Collections
30 day return guarantee, with full refund including original shipping costs for up to 30 days after delivery if an item arrives misdescribed or damaged.
Details
- Title Erythropoietin and the Nervous System
- Author Ahmet Höke
- Binding Hard Cover
- Edition 1st
- Condition New
- Pages 223
- Language ENG
- Publisher Springer, ^^ in Stock: we Ship at Once fr. IL USA;
- Date November 29, 2005
- Features Bibliography, Illustrated, Index
- Bookseller's Inventory # ria9780387300108_pod
- ISBN 9780387300108
From the rear cover
Erythropoietin and the Nervous System is the first book of its kind to bring together researchers from many different disciplines of neuroscience to present a current state-of-the-art review of multiple aspects of erythropoietin research as it relates to the nervous system. Erythropoietin (EPO) is a chemokine hormone that is widely distributed throughout the body. In addition to its traditional role as a hormone that stimulates red blood cell production, in recent years many laboratories have shown that EPO can act as a neuroprotective compound in a variety of injury paradigms in the nervous system. Past experience with the relatively safety profile of this FDA-approved drug makes it an ideal candidate to take into clinical trials for neuroprotection. We are on the verge of major clinical trials using this drug for neuroprotection in diseases ranging from stroke, to transverse myelitis to chemotherapy-induced peripheral neuropathy.
This book should stimulate new research on erythropoietin and the nervous system and bring new investigators to the field. It will benefit scientists and clinicians interested in neuroprotection in the broadest sense.
